These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 4579145)

  • 1. Effect of BCG on carcinogen-induced tumor development in mice.
    Kataoka T; Nakamura RM; Yamamoto S; Tokunaga T; Murohashi T
    Jpn J Med Sci Biol; 1972 Dec; 25(6):377-82. PubMed ID: 4579145
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of oil-attached BCG cell-wall skeleton on the induction of pleural fibrosarcomas in mice.
    Yoshimoto T; Azuma I; Sakatani M; Nishikawa H; Ogura T
    Gan; 1976 Jun; 67(3):441-5. PubMed ID: 793922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapeutic and immunoprophylactic effects of BCG on 3-methylcholanthrene-induced autochthonous tumors in Swiss mice.
    Tokunaga T; Yamamoto S; Nakamura RM; Kataoka T
    J Natl Cancer Inst; 1974 Aug; 53(2):459-63. PubMed ID: 4602061
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of intratumor injection of live BCG on 3-methylcholanthrene-induced tumors of primary and early transplant generations in mice.
    Tanaka T
    Gan; 1974 Apr; 65(2):145-51. PubMed ID: 4600803
    [No Abstract]   [Full Text] [Related]  

  • 5. [Decrease of resistance to tumor induction by bCG vaccination].
    Volegov AI
    Vopr Onkol; 1971 Dec; 17(12):87-9. PubMed ID: 5144168
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of the mode of immunopotentiating action of BCG and wax D. II. Effect on the methylcholanthrene carcinogenesis.
    Ishibashi T; Yamada H; Harada S; Harada Y; Takamoto M; Sugiyama K
    Jpn J Exp Med; 1977 Dec; 47(6):435-40. PubMed ID: 609113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of tumor growth and induction of specific tumor immunity by intradermal inoculation of a mixture of living tumor cells and live Mycobacterium bovis in syngeneic mice.
    Tanaka T; Tokunaga T
    Gan; 1971 Oct; 62(5):433-4. PubMed ID: 4946562
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunotherapy of cancer with cell wall skeleton of Myocabacterium bovis-Bacillus Calmette-Guérin: experimental and clinical results.
    Yamamura Y; Azuma I; Taniyama T; Sugimura K; Hirao F; Tokuzen R; Okabe M; Nakahara W; Yasumoto K; Ohta M
    Ann N Y Acad Sci; 1976; 277(00):209-27. PubMed ID: 826205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of cell-wall skeleton of Mycobacterium bovis BCG on cell-mediated cytotoxicity in tumor-bearing mice.
    Taniyama T; Azuma I; Aladin AA; Yamamura Y
    Gan; 1975 Dec; 66(6):705-9. PubMed ID: 817955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of Listeria factor Ei, BCG vaccine and a combination of both on the growth of experimental syngeneic tumors in inbred mice].
    Zák M; Mára M; Jirkovský J
    Sb Lek; 1989 Sep; 91(8-9):230-7. PubMed ID: 2562579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [RELATIONSHIP BETWEEN CANCER AND TUBERCULOSIS. 2). A RETARDING EFFECT OF BCG INOCULATION FOR TUMOR INDUCTION IN MICE WITH INH OR URETHANE-4 NQO INJECTIONS].
    HATTORI S; MATSUDA M
    Kekkaku; 1964 Oct; 39():449-52. PubMed ID: 14271996
    [No Abstract]   [Full Text] [Related]  

  • 12. [Decreasing tissue resistance to the effects of a carcinogen by strengthening the local response by using BCG].
    Volegov AI; Shchitkov KG
    Vopr Onkol; 1975; 21(5):91-4. PubMed ID: 1210148
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunopotentiation with BCG: dimensions of a specific antitumor response.
    Hawrylko E
    J Natl Cancer Inst; 1975 May; 54(5):1189-97. PubMed ID: 805254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [An attempt to control the growth of syngeneic experimental tumors in inbred mice using Listeria factor Ei, BCG vaccine and a combination of both].
    Zák M; Mára M; Jirkovský J
    Sb Lek; 1989 Sep; 91(8):230-7. PubMed ID: 2617123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage function in tumor-bearing mice: tumoricidal and chemotactic responses of macrophages activated by infection with Mycobacterium bovis, strain BCG.
    Meltzer MS; Stevenson MM
    J Immunol; 1977 Jun; 118(6):2176-81. PubMed ID: 325142
    [No Abstract]   [Full Text] [Related]  

  • 16. Histopathology of Mycobacterium bovis (BCG)-mediated tumor regression.
    Hanna MG; Snodgrass MJ; Zbar B; Rapp HJ
    Natl Cancer Inst Monogr; 1972 Dec; 35():345-58. PubMed ID: 4349152
    [No Abstract]   [Full Text] [Related]  

  • 17. Partial purification of a serum factor that causes necrosis of tumors.
    Green S; Dobrjansky A; Carswell EA; Kassel RL; Old LJ; Fiore N; Schwartz MK
    Proc Natl Acad Sci U S A; 1976 Feb; 73(2):381-5. PubMed ID: 54919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coupling PPD to tumour cells enhances their antigenicity in BCG-primed mice.
    Lachmann PJ; Sikora K
    Nature; 1978 Feb; 271(5644):463-4. PubMed ID: 342968
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunoprophylaxis of methylcholanthrene-induced tumors in mice with Bacillus Calmette-Guérin and methanol-extracted residue.
    Lavrin DH; Rosenberg SA; Connor RJ; Terry WD
    Cancer Res; 1973 Mar; 33(3):472-7. PubMed ID: 4570271
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunopotentiation with BCG. 3. Modulation of the response to a tumor-specific antigen.
    Hawrylko E; Mackaness GB
    J Natl Cancer Inst; 1973 Nov; 51(5):1677-82. PubMed ID: 4587142
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.